View in EDS

Progress and challenges in the development of clinically viable Piezo1 inhibitors.

Saved in:
Bibliographic Details
Title: Progress and challenges in the development of clinically viable Piezo1 inhibitors.
Authors: Baecker D; Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
Source: Future medicinal chemistry [Future Med Chem] 2025 Jul; Vol. 17 (13), pp. 1505-1507. Date of Electronic Publication: 2025 Jul 11.
Publication Type: Editorial
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101511162 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1756-8927 (Electronic) Linking ISSN: 17568919 NLM ISO Abbreviation: Future Med Chem Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40643562
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Progress and challenges in the development of clinically viable Piezo1 inhibitors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Baecker+D%22">Baecker D</searchLink>; Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101511162%22">Future medicinal chemistry</searchLink> [Future Med Chem] 2025 Jul; Vol. 17 (13), pp. 1505-1507. <i>Date of Electronic Publication: </i>2025 Jul 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Editorial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101511162 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1756-8927 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217568919%22">17568919 </searchLink><i>NLM ISO Abbreviation: </i>Future Med Chem <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40643562
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/17568919.2025.2532996
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1505
    Titles:
      – TitleFull: Progress and challenges in the development of clinically viable Piezo1 inhibitors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Baecker D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1756-8927
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 13
          Titles:
            – TitleFull: Future medicinal chemistry
              Type: main
ResultId 1